AGFD 242-Acylation as an approach to increase the bioavailability and enhance the cancer preventive effect of (-)-epigallocatechin-3-gallate

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
Volume234
StatePublished - 2007

Cite this